AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors.
Carmès L, Bort G, Lux F, Seban L, Rocchi P, Muradova Z, Hagège A, Heinrich-Balard L, Delolme F, Gueguen-Chaignon V, Truillet C, Crowley S, Bello E, Doussineau T, Dougan M, Tillement O, Schoenfeld JD, Brown N, Berbeco R.
Carmès L, et al. Among authors: delolme f.
Nanoscale. 2024 Feb 1;16(5):2347-2360. doi: 10.1039/d3nr04777f.
Nanoscale. 2024.
PMID: 38113032